Want to join the conversation?
The biotechnology company $CELG reported a 3Q15 loss due to higher costs on Juno Therapeutics collaboration and expenses on purchase of Receptos. Net loss was $34.1MM or $0.04 per share compared to a profit of $508.5MM or $0.61 per share last year. Revenue grew to $2.33Bil from $1.98Bil. Adjusted EPS rose to $1.23 from $0.97.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.